SynthesisPloS one2019
Systematic review on barriers and enablers for access to diabetic retinopathy screening services in different income settings.
Synthesis in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers, 8 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
102 citing papers in PubMed, 8 syntheses or guidelines pooled it, 166 citations in OpenAlex.
- Diabetic retinopathy treatment cascade and care continuum in the USA: a systematic review.BMJ open · 2026Pooled it
- Economic Evaluation of Diabetic Retinopathy Screening in Developing Countries: A Systematic Review.Korean journal of ophthalmology : KJO · 2025Pooled it
- Describing the Performance and the Infrastructure Requirements of the Existing Artificial Intelligence (AI)-Based Diabetic Retinopathy (DR) Screening Algorithms for Diabetic Patients: an Umbrella Review.Journal of medical systems · 2025Pooled it
- Artificial intelligence versus manual screening for the detection of diabetic retinopathy: a comparative systematic review and meta-analysis.Frontiers in medicine · 2025Pooled it
- Pooled it
- Global Prevalence of Diabetic Retinopathy in Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis.JAMA network open · 2023Pooled it
- Pre-existing diabetic retinopathy as a prognostic factor for COVID-19 outcomes amongst people with diabetes: A systematic review.Diabetes research and clinical practice · 2022Pooled it
- Barriers and facilitators to successful management of type 2 diabetes mellitus in Latin America and the Caribbean: A systematic review.PloS one · 2020Pooled it
- Tele-ophthalmology-enabled and artificial intelligence-ready referral pathway for community optometry referrals of retinal disease: HERMES cluster randomised trial with a diagnostic accuracy study.Health technology assessment (Winchester, England) · 2025Trial
- Health education improves referral compliance of persons with probable Diabetic Retinopathy: A randomized controlled trial.PloS one · 2020Trial
- Revealing the Blind Spots: Linked EHRs Associate Racial and Ethnic Inequities in Diabetic Eye Care Testing.Journal of racial and ethnic health disparities · 2026Article
- Early Detection of Glaucoma and Diabetic Retinopathy in Low-Resource Settings: Barriers and Solutions.Journal of clinical medicine · 2026Review
- Knowledge, attitudes and practices regarding prevention of diabetic eye complications among people living with diabetes in Limpopo province of South Africa: A cross-sectional study.African journal of primary health care & family medicine · 2026Article
- REAL-WORLD PRACTICE OF ARTIFICIAL INTELLIGENCE DIAGNOSTIC SYSTEM FOR DIABETIC RETINOPATHY IN TAIWAN.Retina (Philadelphia, Pa.) · 2026Article
- Prospective Data Curation Enables High-Performance Artificial Intelligence for Diabetic Retinopathy Screening in a Resource-Limited Setting.Ophthalmology science · 2026Article
- Review
- The Burden of Delayed Diabetic Retinopathy Management and Use of Artificial Intelligence-Driven Screening Tools: A Systematic Literature Review.Ophthalmology and therapy · 2026Review
- Barriers to Regular Eye Examination in Individuals with Diabetes at a Tertiary Diabetes Centre in Jordan: A Cross-Sectional Study.International journal of environmental research and public health · 2026Article
- Screening practices, diabetic retinopathy knowledge, and conflict-related barriers to healthcare access among adults with diabetes in Palestine: a cross-sectional study.Frontiers in clinical diabetes and healthcare · 2026Article
- Digital eyes on diabetes: a systematic review of attitudes toward telemedicine-based retinopathy screening.Oxford open digital health · 2026Article
42 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetic retinopathy (DR) can lead to visual impairment and blindness if not detected and treated in time. Knowing the barriers/enablers in advance in contrasting different country income settings may accelerate development of a successful DR screening (DRS) program. This would be especially applicable in the low-income settings with the rising prevalence of DR.
objectivesThe aim of this systematic review is to identify and contrast the barriers/enablers to DRS for different contexts using both consumers i.e., people with diabetes (PwDM) and provider perspectives and system level factors in different country income settings.
methodsWe searched MEDLINE, Embase, CENTRAL in the Cochrane Library from the databases start date to December 2018. We included the studies reported on barriers and enablers to access DRS services based at health care facilities. We categorised and synthesized themes related to the consumers (individuals), providers and the health systems (environment) as main dimensions according to the constructs of social cognitive theory, supported by the quantitative measures i.e., odds ratios as reported by each of the study authors. MAIN
resultsWe included 77 studies primarily describing the barriers and enablers. Most of the studies were from high income settings (72.7%, 56/77) and cross sectional in design (76.6%, 59/77). From the perspectives of consumers, lack of knowledge, attitude, awareness and motivation were identified as major barriers. The enablers were fear of blindness, proximity of screening facility, experiences of vision loss and being concerned of eye complications. In providers' perspectives, lack of skilled human resources, training programs, infrastructure of retinal imaging and cost of services were the main barriers. Higher odds of uptake of DRS services was observed when PwDM were provided health education (odds ratio (OR) 4.3) and having knowledge on DR (OR range 1.3-19.7).
conclusionKnowing the barriers to access DRS is a pre-requisite in development of a successful screening program. The awareness, knowledge and attitude of the consumers, availability of skilled human resources and infrastructure emerged as the major barriers to access to DRS in any income setting.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.